Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Manlutac, Anna Liza M ^a   Giesick, Jill S ^a   McVay, Patricia A ^a  

^a San Diego County EMS   (United States)

Author keywords

4th generation screening assay; Acute HIV infection; HIV antibodies; HIV RNA NAT; HIV 1 p24 antigen; Multispot Rapid Test

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY; FALSE POSITIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION;

4TH GENERATION SCREENING ASSAY; ACUTE HIV INFECTION; HIV ANTIBODIES; HIV RNA NAT; HIV-1 P24 ANTIGEN; MULTISPOT RAPID TEST;

ALGORITHMS; CALIFORNIA; DIAGNOSTIC TESTS, ROUTINE; FLUORESCENT ANTIBODY TECHNIQUE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL; VIROLOGY;

EID: 84890215402     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.031     Document Type: Article

References (11)

1. Clinical and Laboratory Standards Institute (CLSI). Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection; approved guideline. CLSI document M53-A. 2011. p. 10-4.
2. Pandori M., Hackett, Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009, 47:2639-2642.
3. Abbott Laboratories. HIV Ag/Ab combo package insert, version July 2010.
4. U.S.Department United States Census Bureau State and County Quick Facts. Data derived from population estimates 2012, American Community Survey.
5. Centers for Disease Control and Prevention. HIV surveillance report, vol. 23, 2011. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.
6. HIV/AIDS Surveillance in California. California Department of Public Health, Office of AIDS, 2010.
7. HIV/AIDS Surveillance Program Epidemiology Report 2012. http://www.sdcounty.ca.gov/hhsa/programs/phs/hiv_aids_epidemiology_unit/reports_and_statistics.html.
8. Marquez C., Zetola N.M., Klausner J.D. HIV testing: an update. MLO 2008, 40(2):12-21.
9. Marks G., Crepaz N., Janssen R.S. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the United States. AIDS 2006, 20(10):1447-1450. PubMed.
10. Schackman B.R., Gebo K.A., Walensky R.P., Losina E., Muccio T., Sax P.E., et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006, 44(11):990-997.
11. Bio-Rad Laboratories. Multispot HIV-1/HIV-2 rapid test package insert, version March 2013.